Clinical trials
Alzheimer Disease or Associated Disorder clinical trials
Below are recruiting alzheimer disease or associated disorder clinical trials, each written for real people, not researchers. We’re tracking 1,816 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07269847Recruiting
Beef-heavy diet study for adults with pre-diabetes
This study tests whether a diet rich in beef can improve metabolic health in adults with pre-diabetes or metabolic syndrome compared to a typical healthy U.S. diet. Eligible participants will follow one of two meal plans for several weeks.
Guelph, Ontario - onAges 18–74 - NCT07280065RecruitingPhase 3
Testing a smartphone tool for PTSD diagnosis
This study tests a new tool (Senseye) that uses an iPhone camera to help diagnose PTSD. You will have a few video visits and answer questions about your mood and experiences.
Aurora, ColoradoAges 18 years+ - NCT07280416Recruiting
Sleep changes in first year after cancer diagnosis
This study follows people who are newly diagnosed with cancer to see how their sleep changes during the first year. It looks at whether treatments like chemo or immunotherapy affect insomnia.
Le Puy-en-VelayAges 18–80 - NCT07284264Recruiting
Early Alzheimer's detection study using digital tools
This study uses a digital tool to help detect early signs of Alzheimer's disease in people aged 50 and older. It aims to find high-risk individuals who may benefit from early monitoring.
BeijingAges 50 years+ - NCT07284784RecruitingPhase 2/Phase 3
Buntanetap for Parkinson's disease study
This trial tests an investigational drug called buntanetap in people with Parkinson's disease. It aims to see if the drug can improve symptoms. There are two groups: those who've taken buntanetap before (Cohort 1) and those with a deep brain stimulator (DBS) implant for at least a year (Cohort 2).
Birmingham, AlabamaAges 40–85 - NCT07285954Recruiting
Mindful walking study for brain health
This study tests whether a mindful walking program (audio-guided walks) can help people with brain conditions like multiple sclerosis, Parkinson's, or Alzheimer's feel more resilient. If you join, you will be randomly assigned to the walking program or a control group, and you'll wear a Fitbit and do some in-person brain tests.
Urbana, IllinoisAges 18–110 - NCT07288151RecruitingPhase 2
MDMA with Exposure Therapy for PTSD
This trial tests whether MDMA (the drug in ecstasy) combined with a type of talk therapy called massed exposure therapy can help treat PTSD. It may be an option if standard treatments haven't worked well enough.
Atlanta, GeorgiaAges 21–70 - NCT07289191Recruiting
Spinal current stimulation for walking after spinal cord injury
This trial tests whether a new type of electrical stimulation on the back can help improve walking in people with incomplete spinal cord injury. It uses a device that sends small currents through the skin to the spinal cord.
Badalona, BarcelonaAges 18–75 - NCT07294950RecruitingPhase 3
What happens when you stop semaglutide after weight loss
This study looks at what happens to your body and weight when you stop taking semaglutide (Wegovy/Ozempic) after losing at least 10% of your starting weight. The goal is to understand how your metabolism and heart health change once the medication is paused.
Toronto, OntarioAges 18–75 - NCT07294989Recruiting
Blood levels of ciprofol during thyroid surgery
This trial studies how much ciprofol (a type of anesthesia drug) stays in the blood during thyroid surgery. It may help improve dosing for patients like you.
Shenzhen, GuangdongAges 18–65 - NCT07297563RecruitingPhase 2
Anti-CD38 antibody vs rituximab for hard-to-treat ITP
This trial tests a new antibody drug (anti-CD38) compared to a standard drug (rituximab) for adults with ITP that hasn't responded well to steroids. The goal is to see if the new drug works better at raising platelet counts and reducing bleeding risk.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT07297576Recruiting
Sulforaphane to speed blood recovery after cord blood transplant
This trial tests if a natural compound called sulforaphane can help your blood cells recover faster after a cord blood transplant for high-risk blood cancers. If you qualify, you would receive this supplement along with your transplant.
TianjingAges 18 years+ - NCT07302984Recruiting
Mind-body skills groups for teens with war trauma in Gaza
This trial tests if group sessions teaching mind-body skills can help teens in Gaza who have post-traumatic stress disorder (PTSD) from war or political violence. It focuses on young people ages 11-17 who have not had prior therapy or medication for mental health issues.
Deir al-BalahAges 11–17 - NCT07304674Recruiting
Primary Aldosteronism and Thinking Ability Study
This study looks at whether primary aldosteronism (a treatable cause of high blood pressure) is linked to memory and thinking problems. It may help understand if managing this condition can protect brain health.
Chengdu, SichuanAges 40 years+ - NCT07311343RecruitingPhase 4
Mouth care and antibiotics to prevent pneumonia after brain bleed
This trial tests whether a special mouth rinse and preventive antibiotics can lower the risk of pneumonia after a brain bleed (intracerebral hemorrhage). If you've had a small bleed in the upper part of the brain and are at risk for pneumonia, this study may help.
Beijing, Beijing MunicipalityAges 18–80 - NCT07317076Recruiting
Magnetic device study for stomach and bowel blockages
This trial tests a new magnetic device that creates a connection between parts of your stomach or small intestine without needing stitches, for people with certain blockages or digestive issues.
Westmount, QuebecAges 18 years+ - NCT07319039Recruiting
Brain scan study of breathlessness in cancer, COPD, and heart failure
This study uses a brain scan (fMRI) to learn how the brain processes shortness of breath in people with advanced heart failure, COPD, or lung cancer. It aims to help doctors better understand and treat breathlessness.
Geneva, Canton of GenevaAges 18 years+ - NCT07325526RecruitingPhase 2
Testing a new drug for liver cirrhosis from fatty liver disease
This trial tests if a new medicine, BI 3802876, is safe and tolerable for people with compensated liver cirrhosis caused by MASH (a type of fatty liver disease). Participants must have early-stage cirrhosis without complications like fluid buildup or bleeding.
Chandler, ArizonaAges 18–75 - NCT07338682RecruitingPhase 2
L-Arginine for memory in older adults
This trial tests if L-Arginine, a natural amino acid, can improve thinking and memory in adults over 60 with mild to moderate memory problems. You may join if you have no other brain diseases or certain health conditions.
CairoAges 60 years+ - NCT07345221Recruiting
Cold therapy for nerve pain from breast cancer chemo
This trial tests whether cooling the hands and feet during taxane chemotherapy can prevent or reduce nerve pain (peripheral neuropathy). It may help breast cancer patients who have not had nerve problems before.
IstanbulAges 18 years+ - NCT07176286RecruitingPhase 2
PET scan study for diagnosing Lewy body dementia
This trial is testing a special PET scan that uses a radioactive tracer (18F-mFBG) to see how much it is taken up by the heart. The goal is to help tell Lewy body disease (Parkinson's or Lewy body dementia) apart from other brain disorders.
Houston, TexasAges 18 years+ - NCT06902974RecruitingPhase 2
Psilocybin therapy for PTSD from sexual assault
This trial tests whether psilocybin, a psychedelic drug given in a supportive therapy setting, can help women heal from post-traumatic stress disorder (PTSD) caused by a sexual assault that happened 6 or more months ago. You'll receive the drug during supervised sessions and attend therapy visits to see if it reduces your PTSD symptoms.
Rockville, MarylandAges 18 years+ - NCT07679074Recruiting
Samphire guided care program for women's mood and brain fog
This 12-week program tests a mobile app and gentle brain stimulation device designed to help women manage mood and thinking problems linked to their menstrual cycle, perimenopause, or menopause. It aims to improve day-to-day well-being, work productivity, and overall quality of life.
San Francisco, CaliforniaAges 18–65 - NCT02504853Recruiting
Study food allergy patterns and genetics over time
This study follows people with food allergy and some closely related or healthy people to learn how food allergy (and related conditions) develops over time. It may help researchers find causes and better ways to predict and treat food allergy.
Bethesda, MarylandAges 1 day–99 years
Hear when a new Alzheimer Disease or Associated Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for alzheimer disease or associated disorder?
- Yes. Clin2 currently lists 1,816 recruiting alzheimer disease or associated disorder studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a alzheimer disease or associated disorder trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a alzheimer disease or associated disorder trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.